Compare BridgeBio Pharma Inc (BBIO) vs Ford Motor Company (F) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Ford Motor Company — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while Ford Motor Company trades at $14 (market cap $55.83B). The key difference: Ford Motor Company is far larger — about 3.4× BridgeBio Pharma Inc's market cap, and Ford Motor Company pays a 4.29% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | F | |
|---|---|---|
Market Cap | $16.61B | $55.83B |
Sector | Health | Consumer Cyclical |
52-Week High | $90.17 | $17.44 |
52-Week Low | $47.29 | $11.21 |
Enterprise Value | $18.16B | $187.79B |
Dividend Yield | — | 4.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →
